Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
nxn-188 (3 trials)
nxn-462 (1 trial)
sumatriptan (zecuity) (1 trial)
Headache (Phase 2)
Migraine Disorders (Phase 2)
Migraine with Aura (Phase 2)
Migraine without Aura (Phase 2)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 2)
Trials (4 total)
Trial APIs (3 total)